78795-23-0 Usage
Type of Compound
Reversible fatty acid amide hydrolase (FAAH) inhibitor
Target Enzyme
FAAH (an enzyme that breaks down the endocannabinoid anandamide)
Mechanism of Action
Inhibits FAAH, leading to increased levels of anandamide in the brain
Potential Therapeutic Effects
a. Pain relief
b. Anti-inflammatory
c. Anti-anxiety
Other Potential Applications
a. Treatment of mood disorders
b. Treatment of addiction
c. Treatment of neurodegenerative diseases
Additional Properties
a. Neuroprotective effects
b. Anti-cancer properties
Molecular Weight
247.3 g/mol
Appearance
White to off-white solid
Solubility
Soluble in organic solvents such as methanol, ethanol, and dimethyl sulfoxide (DMSO)
Stability
Stable under normal laboratory conditions
Safety Precautions
Handle with care, as the compound may have potential side effects and should be used in accordance with relevant guidelines and regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 78795-23-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,7,9 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 78795-23:
(7*7)+(6*8)+(5*7)+(4*9)+(3*5)+(2*2)+(1*3)=190
190 % 10 = 0
So 78795-23-0 is a valid CAS Registry Number.
78795-23-0Relevant articles and documents
Polymethylene derivatives of pyrimidine nucleic bases bearing ω-functional groups
Makinsky,Kritzyn,Uljanova,Zakharova,Nevinsky
, p. 662 - 668 (2007/10/03)
N1-Acyclic derivatives of pyrimidine bases (uracil, thymine, and cytosine) with hydrophobic polymethylene chains containing various functional groups in an ω-position of the alkyl substituent were synthesized. Their physicochemical properties and inhibitory effect on the HIV reverse transcriptase and human DNA topoisomerase I were studied.
5-ALKOXYMETHYL-1-HYDROXYALKYLURACILS WITH POTENTIAL ANTI-HIV ACTIVITY
Abdel-Megied, Ahmed E.-S.,Motawia, Mohammed S.,Pedersen, Erik B.,Nielsen, Carsten M.
, p. 713 - 722 (2007/10/02)
Acid catalyzed etherification of 5-hydroxymethyluracil (3) afforded the corresponding 5-alkoxymethyluracils (4a-h).Treatment of the sodium salt of compounds (4a-g) with 4-bromobutyl acetate afforded 1,3-bis-(4-acetyloxybutyl)- (5a-g) and 1-4-acetyloxybuty
